Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) for CNY 0 on January 19, 2024. As of September 30, 2023, in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. generated total assets of CNY 3.1 million and net assets of CNY 3.1 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.65 CNY | +0.20% | -1.45% | -26.32% |
1st Jan change | Capi. | |
---|---|---|
-26.32% | 215M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. for CNY 0.